Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on Jun 01, 2020 1:15pm
148 Views
Post# 31097184

RE:RE:RE:RE:SVA trades & Level II at Close of 19½ cents

RE:RE:RE:RE:SVA trades & Level II at Close of 19½ centsQuest,

To answer your question from the previous blog. Sertoli cells and microencapsulation do work. Serotoli technique involves introducing two types of cells in the pouch which require regulatory clearance. Microencapsulation does work as well , individual cells are coated with a polymer . Problem with microencapsulation is that a polymermatrix is required. which mean you need more space for the pouch itself.  AgeX technology is advanced gene therapy .... get consistent and predictable results that allow you to scale up unlimited number of immune protected cells. Other pharma companies are also working with AgeX right now . Sva has stem cells from Unh that they can use in the pouch for this collaboration and I don’t think it will take too long to see results which AgeX won’t hesitate to show.

Elgin 
Bullboard Posts